<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="82771">
  <stage>Registered</stage>
  <submitdate>17/04/2008</submitdate>
  <approvaldate>20/05/2008</approvaldate>
  <actrnumber>ACTRN12608000257369</actrnumber>
  <trial_identification>
    <studytitle>Long term outcome after endoscopic treatment of necrosis due to pancreatitis.</studytitle>
    <scientifictitle>Transluminal Endoscopic Necrosectomy
after Acute Pancreatitis: a Multicenter Study with Long-Term Follow-up (the GEPARD Study). Evaluation of peri- and post-procedural mortality and morbidity as well as long-term follow-up evaluation of survival, indication to surgery and quality of life.</scientifictitle>
    <utrn />
    <trialacronym>GEPARD</trialacronym>
  </trial_identification>
  <conditions>
    <healthcondition>Infected retroperitoneal necrosis</healthcondition>
    <healthcondition>acute necrotizing pancreatitis</healthcondition>
    <conditioncode>
      <conditioncode1>Oral and Gastrointestinal</conditioncode1>
      <conditioncode2>Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Transluminal endoscopic necrosectomy: 1)transgastric or transduodenal access to the retroperitoneal cavity using endoscopic or endosonographic guidance. 2)balloon dilation of the access was carried out to permit the introduction of a conventional gastroscope to allow forceful irrigation and suction, as well as active endoscopic removal of debris using snares, forceps, and stone removal baskets. 3)Repeated sessions at intervals of 14 days were carried out until all debris and necrotic material had been removed and the walls of the collections could be seen as vital structures. The duration of a session was determined mainly by patient tolerance of sedation or general anesthesia, but was usually limited to 90 minutes.</interventions>
    <comparator>no control, description of outcome of treatment only</comparator>
    <control>Uncontrolled</control>
    <interventioncode>Other interventions</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>all cause mortality.</outcome>
      <timepoint>at two to eight years after end of enrollment</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>incidence of pancreatic complications</outcome>
      <timepoint>at two to eight years after end of enrollment</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>quality of life was measured using a simplyfied  pancreatitis centered QOL questionare.</outcome>
      <timepoint>at two to eight years after end of enrollment</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>infected peripancreatic / retroperitoneal necrosis</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Gastric varices</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Observational</studytype>
    <purpose />
    <allocation />
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs>Natural history</purposeobs>
    <duration>Longitudinal</duration>
    <selection>Convenience sample</selection>
    <timing>Retrospective</timing>
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/01/1999</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>120</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up complete</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Germany</country>
      <state />
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Hospital</primarysponsortype>
    <primarysponsorname>Charite - Medizinische Klinik m.S. Gastroenterologie</primarysponsorname>
    <primarysponsoraddress>- Mittelallee 11 -
Augustenburger Platz 1
13353 Berlin</primarysponsoraddress>
    <primarysponsorcountry>Germany</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Hospital</fundingtype>
      <fundingname>Charite - Medizinische Klinik m.S. Gastroenterologie</fundingname>
      <fundingaddress>- Mittelallee 11 -
Augustenburger Platz 1
13353 Berlin</fundingaddress>
      <fundingcountry>Germany</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>infected necrosis after acute necrotizing pancreatitis was treated with a transluminal endoscopic approach.  the long term clinical outcome was evaluated retrospectively over a follow-up of 2 to 8 years.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Ethikkommission der Charite</ethicname>
      <ethicaddress>Chariteplatz 1
10117 Berlin</ethicaddress>
      <ethicapprovaldate>31/03/2008</ethicapprovaldate>
      <hrec>EA2/040/08</hrec>
      <ethicsubmitdate>27/03/2008</ethicsubmitdate>
      <ethiccountry>Germany</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Michael Biermer</name>
      <address>Medizinische Klinik m.S. Gastroenterologie
-Mittelallee 11-
Augustenburger Platz
13353 Berlin</address>
      <phone>+4930450553072</phone>
      <fax />
      <email>michael.biermer@charite.de</email>
      <country>Germany</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Michael Biermer</name>
      <address>Medizinische Klinik m.S. Gastroenterologie
-Mittelallee 11-
Augustenburger Platz
13353 Berlin</address>
      <phone>+4930450553072</phone>
      <fax />
      <email>michael.biermer@charite.de</email>
      <country>Germany</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>same as above</name>
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>